NEXION TECH(08420.HK)组合营 开发系统运行SaaS平台
NEXION TECH(08420.HK)公布,旗下全资附属辉星与奥普及福礼派订立合营协议,同意成立合营公司。辉星、奥普及福礼派将分别拥有该公司55%、25%及20%的权益。合营公司的总注册资本将为2,000万元人民币。
合营公司将透过其自主开发的系统运行SaaS平台为个体工商户及企业提供综合服务,包括系统开发及维护(SaaS服务)、信息发布及交易查询、对盘及处理、订单查询及管理、定价建议及谘询以及交易合约及证书托管。
公司指,成立合营公司有助集团利用奥普及福礼派的资源及专业技能,同时拓扩其於内地的资讯及通讯技术服务,从而将拓宽集团的收入来源及改善财务状况。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.